AMSTERDAM, June 14 (Reuters) – Philips, the Dutch
medical equipment company, on Monday said it would recall
ventilators and “CPAP” breathing devices from the U.S. market
due to a foam part that might degrade and be inhaled.

The company said that though the matter would cause “revenue
headwinds” in its sleep & respiratory care division, that would
be compensated by strength in other businesses and it left its
full year financial guidance unchanged.
(Reporting by Toby Sterling; Editing by Christopher Cushing)